Related Experiment Video

Updated: Aug 3, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Left ventricular function following thrombolytic therapy for myocardial infarction

J K French1, H D White

  • 1Cardiology Department, Green Lane Hospital, Auckland, New Zealand.

Clinical and Experimental Pharmacology & Physiology
|March 1, 1995
PubMed

Insights

Measuring left ventricular function is crucial for assessing thrombolytic therapy effectiveness after myocardial infarction. Improved left ventricular function significantly correlates with reduced mortality, guiding treatment strategies.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Thrombolytic therapy has significantly reduced mortality from cardiac failure post-myocardial infarction.
  • Left ventricular function remains a critical prognostic indicator following acute myocardial infarction recovery.

Purpose of the Study:

  • To evaluate the utility of left ventricular function measurements in assessing thrombolytic agent efficacy.
  • To determine the prognostic value of left ventricular function in the context of thrombolytic therapy.

Main Methods:

  • Systematic review of published studies.
  • Analysis of clinical trials assessing left ventricular function and survival outcomes.
  • Examination of data from the Global Utility of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO) Trial.

Main Results:

  • Three trials demonstrated improved left ventricular function and survival with thrombolytic therapy compared to placebo.
  • Left ventricular function, assessed via ejection fraction, end-systolic volume, or infarct zone contractility at 90 minutes, strongly correlated with 30-day mortality (P < 0.01).
  • The GUSTO Trial findings support the correlation between left ventricular function and mortality reduction.

Conclusions:

  • Left ventricular function is a key metric for evaluating the effectiveness of thrombolytic agents and adjuvant regimens.
  • Accurate assessment of left ventricular function aids in predicting patient outcomes after myocardial infarction treated with thrombolytics.

More Related Videos

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography08:13

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography

Published on: February 16, 2016

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs08:19

Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs

Published on: July 12, 2022

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...